Article Text
PostScript
Letter
Recommended technology to relieve oral mucositis not yet available for children or young people in England or Wales
Statistics from Altmetric.com
Footnotes
Contributors All authors contributed to the background information and letter.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests MR, KH and RP are undertaking a systematic review on the use of LLLT to prevent or treat oral mucositis in children with cancer (PROSPERO registration: CRD42018099772).
Patient consent for publication Parental consent obtained.
Provenance and peer review Not commissioned; internally peer reviewed.